Vaxart Inc (NASDAQ: VXRT)
$0.67
+0.0033 ( +0.49% ) 1.8M
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Market Data
Open
$0.67
Previous close
$0.67
Volume
1.8M
Market cap
$120.03M
Day range
$0.66 - $0.72
52 week range
$0.52 - $1.54
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Mar 06, 2024 |
8-k | 8K-related | 18 | Feb 29, 2024 |
8-k | 8K-related | 15 | Feb 15, 2024 |
8-k/a | 8K-related | 16 | Feb 02, 2024 |
8-k | 8K-related | 14 | Jan 19, 2024 |
8-k | 8K-related | 15 | Jan 16, 2024 |
8-k | 8K-related | 18 | Jan 16, 2024 |
10-q | Quarterly Reports | 70 | Nov 02, 2023 |
8-k | 8K-related | 14 | Nov 02, 2023 |
8-k/a | 8K-related | 13 | Oct 23, 2023 |